PSMA and 18F-FDG PET Imaging in the Treatment of Metastatic Prostate Cancer with 223Ra: Initial Application and Experience

Objective  To share our experience of the use of prostate specific membrane antigen (PSMA) and/or 18F-fluoroodexyglucose (18F-FDG) positron emission tomography (PET) in the setting of radium-223 dichloride (223Ra) in treatment of bone metastases of prostate cancer in order to broaden the know-ledge...

Full description

Bibliographic Details

Published in:	Xiehe Yixue Zazhi
Main Authors:	HU Guilan, TIAN Jian, LI Yongqiang, JI Zhigang, HUO Li, CHEN Yonghui
Format:	Article
Language:	Chinese
Published:	Editorial Office of Medical Journal of Peking Union Medical College Hospital 2023-07-01
Subjects:	prostate cancer radium-223 dichloride prostate specific membrane antigen fdg
Online Access:	https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2023-0152